Clinical Trials Directory

Trials / Completed

CompletedNCT01857050

Assessment of International Normalized Ratio (INR) Prolongation in Patients Treated Simultaneously With Warfarin and Cephalosporins

Assessment of INR Prolongation in Patients Treated Simultaneously With Warfarin and Antibiotics From the Cephalosporins Family,Observational Retrospective Study.

Status
Completed
Phase
Study type
Observational
Enrollment
236 (actual)
Sponsor
Meir Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Many drug interactions with Warfarin are well documented in the literature, including interactions with a variety of antibiotics. However,in mamy cases it is difficult to predict when the interaction remains theoretical and when it becomes clinically significant and will be reflected in the individual patient. This study's aim is to identify and characterize related conditions (including comorbidities, laboratory test results and other parameters related to the patient)that might be predictors for drug interactions turning from theoretical to clinically significant.

Conditions

Timeline

Start date
2013-04-01
Primary completion
2014-01-01
Completion
2014-01-01
First posted
2013-05-20
Last updated
2014-02-25

Source: ClinicalTrials.gov record NCT01857050. Inclusion in this directory is not an endorsement.

Assessment of International Normalized Ratio (INR) Prolongation in Patients Treated Simultaneously With Warfarin and Cep (NCT01857050) · Clinical Trials Directory